BCA
DRNA

Berman Capital Advisors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Berman Capital Advisors’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		$1K Buy
61
+57
+1,425% +$934 ﹤0.01% 2037
2021
Q2 		$0 Buy
+4
New – ﹤0.01% 2110